• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫西沙星以剂量和时间依赖性方式激活SOS反应。

Moxifloxacin Activates the SOS Response in in a Dose- and Time-Dependent Manner.

作者信息

Iacobino Angelo, Piccaro Giovanni, Pardini Manuela, Fattorini Lanfranco, Giannoni Federico

机构信息

Dipartimento di Malattie Infettive, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Organismo Notificato Unificato, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

出版信息

Microorganisms. 2021 Jan 27;9(2):255. doi: 10.3390/microorganisms9020255.

DOI:10.3390/microorganisms9020255
PMID:33513836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911356/
Abstract

Previous studies on demonstrated that sub-minimum inhibitory concentration (MIC) of fluoroquinolones induced the SOS response, increasing drug tolerance. We characterized the transcriptional response to moxifloxacin in . Reference strain H37Rv was treated with moxifloxacin and gene expression studied by qRT-PCR. Five SOS regulon genes, , , , and were induced in a dose- and time-dependent manner. A range of moxifloxacin concentrations induced , with a peak observed at 2 × MIC (0.25 μg/mL) after 16 h. Another seven SOS responses and three DNA repair genes were significantly induced by moxifloxacin. Induction of by moxifloxacin was higher in log-phase than in early- and stationary-phase cells, and absent in dormant bacilli. Furthermore, in an H37Rv fluoroquinolone-resistant mutant carrying the D94G mutation in the gene, the SOS response was induced at drug concentrations higher than the mutant MIC value. The 2 × MIC of moxifloxacin determined no significant changes in gene expression in a panel of 32 genes, except for up-regulation of the toxin and of and , two persistence-related genes. Overall, our data show that activation of the SOS response by moxifloxacin, a likely link to increased mutation rate and persister formation, is time, dose, physiological state and, possibly, MIC dependent.

摘要

先前关于……的研究表明,氟喹诺酮类药物的亚最小抑菌浓度(MIC)可诱导SOS反应,增加耐药性。我们对……中莫西沙星的转录反应进行了表征。用莫西沙星处理参考菌株H37Rv,并通过qRT-PCR研究基因表达。五个SOS调控子基因,……、……、……、……和……以剂量和时间依赖性方式被诱导。一系列莫西沙星浓度均可诱导……,在16小时后2×MIC(0.25μg/mL)时观察到峰值。另外七个SOS反应和三个DNA修复基因也被莫西沙星显著诱导。莫西沙星对……的诱导在对数期高于早期和稳定期细胞,而在休眠芽孢杆菌中不存在。此外,在携带……基因D94G突变的H37Rv氟喹诺酮耐药突变体中,在药物浓度高于突变体MIC值时诱导了SOS反应。莫西沙星的2×MIC在一组32个基因中未引起基因表达的显著变化,除了……毒素以及两个与持续存在相关的基因……和……的上调。总体而言,我们的数据表明,莫西沙星激活SOS反应,这可能与突变率增加和持续菌形成有关,是时间、剂量、生理状态以及可能与MIC相关的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/2fa7a81e0f41/microorganisms-09-00255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/3a5eebae81f3/microorganisms-09-00255-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/b6c08a28a951/microorganisms-09-00255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/2fa7a81e0f41/microorganisms-09-00255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/3a5eebae81f3/microorganisms-09-00255-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/b6c08a28a951/microorganisms-09-00255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c93/7911356/2fa7a81e0f41/microorganisms-09-00255-g003.jpg

相似文献

1
Moxifloxacin Activates the SOS Response in in a Dose- and Time-Dependent Manner.莫西沙星以剂量和时间依赖性方式激活SOS反应。
Microorganisms. 2021 Jan 27;9(2):255. doi: 10.3390/microorganisms9020255.
2
Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?莫西沙星和左氧氟沙星治疗广泛耐药结核病的效果相同吗?
J Antimicrob Chemother. 2017 Aug 1;72(8):2326-2333. doi: 10.1093/jac/dkx150.
3
Efficient repair of hydrogen peroxide-induced DNA damage by Escherichia coli requires SOS induction of RecA and RuvA proteins.大肠杆菌对过氧化氢诱导的DNA损伤进行有效修复需要SOS诱导RecA和RuvA蛋白。
Mutat Res. 2000 Apr 28;459(3):187-94. doi: 10.1016/s0921-8777(99)00073-7.
4
Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulation.暴露于多种抗菌药物会通过 SOS 依赖性调控诱导 qnrB1、qnrD 和 smaqnr 基因的表达。
J Antimicrob Chemother. 2012 Dec;67(12):2854-9. doi: 10.1093/jac/dks326. Epub 2012 Aug 22.
5
Effect of rifampicin and gentamicin on Shiga toxin 2 expression level and the SOS response in Escherichia coli O104:H4.利福平与庆大霉素对肠出血性大肠杆菌O104:H4中志贺毒素2表达水平及SOS反应的影响
Foodborne Pathog Dis. 2015 Jan;12(1):47-55. doi: 10.1089/fpd.2014.1824. Epub 2014 Nov 10.
6
Induction of the SOS regulon of Haemophilus influenzae does not affect phase variation rates at tetranucleotide or dinucleotide repeats.流感嗜血杆菌SOS调节子的诱导不影响四核苷酸或二核苷酸重复序列处的相变率。
Microbiology (Reading). 2005 Aug;151(Pt 8):2751-2763. doi: 10.1099/mic.0.27996-0.
7
Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.氟喹诺酮与结核分枝杆菌gyrase的相互作用:增强对野生型和耐药gyrase的药物活性。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E839-46. doi: 10.1073/pnas.1525055113. Epub 2016 Jan 20.
8
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌临床分离株中 gyrA 突变与氧氟沙星和莫西沙星表型敏感性水平的关系。
J Antimicrob Chemother. 2012 May;67(5):1088-93. doi: 10.1093/jac/dks033. Epub 2012 Feb 22.
9
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.化脓性链球菌emm6型中高水平氟喹诺酮耐药性的出现以及环丙沙星、左氧氟沙星和莫西沙星的体外耐药性选择。
J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.
10
High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.台湾地区引起泌尿道感染的结核分枝杆菌分离株中氟喹诺酮类药物耐药率高及外排泵抑制剂对莫西沙星耐药性的影响。
Int J Antimicrob Agents. 2017 Sep;50(3):491-495. doi: 10.1016/j.ijantimicag.2017.04.010. Epub 2017 Jun 28.

引用本文的文献

1
Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action.多模态测量的整合确定了结核病药物作用的关键机制。
Cell Syst. 2025 Aug 20;16(8):101348. doi: 10.1016/j.cels.2025.101348. Epub 2025 Jul 29.
2
Toward a Bactericidal Oral Drug Combination for the Treatment of Lung Disease.研发用于治疗肺部疾病的杀菌性口服药物组合。
ACS Infect Dis. 2025 Apr 11;11(4):929-939. doi: 10.1021/acsinfecdis.4c00948. Epub 2025 Apr 1.
3
Identification of Rv1133c (MetE) as a marker of replication and as a highly immunogenic antigen with potential immunodiagnostic power.

本文引用的文献

1
Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in .CRISPRi 条件性沉默揭示了 DNA 拓扑异构酶在 中形成药物耐受持久种群中的作用。
Front Cell Infect Microbiol. 2019 Mar 26;9:70. doi: 10.3389/fcimb.2019.00070. eCollection 2019.
2
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.结核分枝杆菌在中性pH值的低氧环境中被利福平及利福喷汀选择性杀灭。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02296-16. Print 2017 Mar.
3
De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.
鉴定 Rv1133c(MetE)为复制标志物和具有潜在免疫诊断能力的高度免疫原性抗原。
Front Immunol. 2024 Oct 4;15:1464923. doi: 10.3389/fimmu.2024.1464923. eCollection 2024.
4
Eradication of Drug-Tolerant 2022: Where We Stand.2022年耐药菌根除:我们的现状
Microorganisms. 2023 Jun 6;11(6):1511. doi: 10.3390/microorganisms11061511.
5
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.非嵌入型细菌拓扑异构酶抑制剂的进展:DNA促旋酶和拓扑异构酶IV的变构抑制剂及ATP酶抑制剂
Pharmaceuticals (Basel). 2023 Feb 8;16(2):261. doi: 10.3390/ph16020261.
6
Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: A retrospective study revealed by whole genome sequencing.复发性肺结核中的内源性复发和外源性再感染:一项通过全基因组测序揭示的回顾性研究
Front Microbiol. 2023 Feb 17;14:1115295. doi: 10.3389/fmicb.2023.1115295. eCollection 2023.
7
Microfluidic dose-response platform to track the dynamics of drug response in single mycobacterial cells.微流控剂量反应平台,用于跟踪单个分枝杆菌细胞中药物反应的动力学。
Sci Rep. 2022 Nov 15;12(1):19578. doi: 10.1038/s41598-022-24175-9.
8
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.螺吡喃并嘧啶酮类 DNA 拓扑异构酶抑制剂具有强大且选择性的抗结核活性。
J Med Chem. 2022 May 12;65(9):6903-6925. doi: 10.1021/acs.jmedchem.2c00266. Epub 2022 May 2.
9
Structure-Activity Relationship of Anti- Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors.新型NBTI DNA回旋酶抑制剂——抗哌啶-4-羧酰胺的构效关系
ACS Med Chem Lett. 2022 Feb 28;13(3):417-427. doi: 10.1021/acsmedchemlett.1c00549. eCollection 2022 Mar 10.
10
Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones.螺吡喃并嘧啶酮类:一类对结核分枝杆菌有活性且与氟喹诺酮类药物无交叉耐药性的 DNA 拓扑异构酶抑制剂。
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0219221. doi: 10.1128/aac.02192-21. Epub 2022 Mar 10.
体外针对抗结核药物形成的持留期细胞中结核分枝杆菌遗传抗性突变体的从头出现。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01343-16. Print 2017 Feb.
4
Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.氟喹诺酮与结核分枝杆菌gyrase的相互作用:增强对野生型和耐药gyrase的药物活性。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E839-46. doi: 10.1073/pnas.1525055113. Epub 2016 Jan 20.
5
P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality.P1核酸内切酶:噬菌体增强抗生素致死性的分子机制
PLoS Genet. 2016 Jan 14;12(1):e1005797. doi: 10.1371/journal.pgen.1005797. eCollection 2016 Jan.
6
Overexpression of SOS genes in ciprofloxacin resistant Escherichia coli mutants.环丙沙星耐药大肠杆菌突变体中SOS基因的过表达
Gene. 2016 Jan 15;576(1 Pt 1):115-8. doi: 10.1016/j.gene.2015.09.069. Epub 2015 Oct 2.
7
Multiple toxin-antitoxin systems in Mycobacterium tuberculosis.结核分枝杆菌中的多种毒素-抗毒素系统。
Toxins (Basel). 2014 Mar 6;6(3):1002-20. doi: 10.3390/toxins6031002.
8
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.有氧和低氧酸性条件下生长的结核分枝杆菌的药物组合活性。
Antimicrob Agents Chemother. 2013 Mar;57(3):1428-33. doi: 10.1128/AAC.02154-12. Epub 2013 Jan 7.
9
Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine.莫西沙星治疗肺结核患者的群体药代动力学研究及间歇高剂量利福喷汀的影响。
Antimicrob Agents Chemother. 2012 Aug;56(8):4471-3. doi: 10.1128/AAC.00404-12. Epub 2012 May 14.
10
Mycobacterium tuberculosis: success through dormancy.结核分枝杆菌:休眠中的成功之道。
FEMS Microbiol Rev. 2012 May;36(3):514-32. doi: 10.1111/j.1574-6976.2012.00331.x. Epub 2012 Mar 8.